During the past decade, Clinica de Pesquisa e Centro de Estudos em Oncologia Ginecologica e Mamaria Ltda conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 5 clinical trials were completed, i.e. on average, 27.8% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 5 clinical trials were completed. i.e. 38.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinica de Pesquisa e Centro de Estudos em Oncologia Ginecologica e Mamaria Ltda" #1 sponsor was "Hoffmann-La Roche" with 12 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Agenus Inc." with 1 trials sponsored, "CanariaBio Inc." with 1 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica de Pesquisa e Centro de Estudos em Oncologia Ginecologica e Mamaria Ltda" #1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Clinica de Pesquisa e Centro de Estudos em Oncologia Ginecologica e Mamaria Ltda" are "Breast Neoplasms" (2 trials), "Cervical Cancer" (2 trials), "Metastatic Breast Cancer" (2 trials), "Ovarian Cancer" (2 trials) and "Peritoneal Neoplasms" (2 trials). Many other conditions were trialed in "Clinica de Pesquisa e Centro de Estudos em Oncologia Ginecologica e Mamaria Ltda" in a lesser frequency.

Most popular intervention types in "Clinica de Pesquisa e Centro de Estudos em Oncologia Ginecologica e Mamaria Ltda" are "Drug" (18 trials), "Biological" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (7 trials), "Paclitaxel" (5 trials), "Giredestrant" (4 trials), "Placebo" (4 trials) and "Carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Clinica de Pesquisa e Centro de Estudos em Oncologia Ginecologica e Mamaria Ltda" are 11 trials for "All" genders and 7 trials for "Female" genders.

Currently, there are NaN active trials in "Clinica de Pesquisa e Centro de Estudos em Oncologia Ginecologica e Mamaria Ltda". undefined are not yet recruiting, 5 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Clinica de Pesquisa e Centro de Estudos em Oncologia Ginecologica e Mamaria Ltda, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinica de Pesquisa e Centro de Estudos em Oncologia Ginecologica e Mamaria Ltda, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".